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We report the isolation and characterization of a new inhibitory Smad in Xenopus, which we have designated as Xenopus
Smad7. Smad7 is present at fairly constant levels throughout early development and at blastula stages enriched in the
ventral side of the animal hemisphere. The induction of mesoderm by TGF-b-like signals is mediated by receptor ALK-4 and
we show that Smad7 blocks signaling of ALK-4 in a graded fashion: lower levels of Smad7 block activation of dorsal
mesoderm genes and higher levels block all mesoderm genes expression. Smad7 is able to directly activate neural markers
in explants in the absence of mesoderm or endoderm. This neural-inducing activity of Smad7 may be due to inhibition of
BMP-4 signaling because Smad7 can also block BMP-4-mediated mesoderm induction. Thus, Smad7 acts as a potent
inhibitor of mesoderm formation and also activates the default neural induction pathway. © 1998 Academic Press
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INTRODUCTION
Understanding the processes that lead to formation of the
germ layers in an embryo is key to understanding how the
spatial organization of an animal emerges from a fertilized
egg. During vertebrate embryogenesis, inductive processes
involving cell interactions are known to play a key role in
specification of cell fates and the formation of germ layers
(reviewed in Jessell and Melton, 1992). In Xenopus, the
marginal zone cells of the animal hemisphere adopt a
mesodermal fate in response to inductive signals that
originate from the underlying endoderm. Ectoderm arises
from animal pole cells that do not become mesoderm.
Dorsal ectoderm forms the nervous system in response to
signals from the dorsal marginal zone (DMZ), the site of the
Spemann’s organizer, while ventral ectoderm does not
receive these signals and forms epidermis (reviewed in
Heasman, 1997).
This cascade of signaling relies in large part on secreted
molecules of the TGF-b family (reviewed in Kessler and
Melton, 1994). The TGF-b family members signal through
heteromeric receptor complexes: the ligand binds to the
type II receptors followed by the recruitment of a type I
receptor into a complex which then initiates the signaling
cascade (Wrana et al., 1994). The type I receptors, known as
ALKs (activin receptor-like kinases) activate downstream
target proteins known as Smads which subsequently trans-
locate to the nucleus and cooperate with other proteins to
activate transcription (Chen et al., 1997a). Although the
exact identities of the signals utilized in the embryo remain
unclear in many cases (Smith, 1995), isolation and charac-
terization of receptors that mediate the signals of the
TGF-b-like ligands and Smad proteins provide new tools to
study the mechanisms that govern embryonic induction. In
Xenopus, at the blastula stage, the induction of mesoderm
and the formation of the Spemann’s organizer appear to be
mediated by the receptor ALK-4 and its downstream target,
Smad2 (Bhushan and Vale, manuscript submitted; Baker
and Harland, 1996; Chang et al., 1997). During gastrula
stages, the receptor ALK-3 and Smad1 mediate BMP-4
signals to actively maintain ventral fates in the animal
hemisphere and to attenuate dorsalizing signals emanating
from the organizer (Graff et al., 1994). Such analyses are
beginning to unravel how an early developing embryo
controls spatial patterns of transcription factors through
intercellular signaling.
A number of recent studies have suggested that the
establishment of dorsal–ventral pattern of gene expression
in the gastrula-stage Xenopus embryo involves the interac-
tion of stimulatory and inhibitory signaling (reviewed in
Wilson and Hemmati-Brivanlou, 1997). Noggin and chordin
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are dorsalizing factors secreted by the Spemann’s organizer
that inhibit BMP-4-mediated ventral signals by directly
binding to and inactivating BMP-4 (Piccolo et al., 1996;
Zimmerman et al., 1996). Thus active signaling by BMP-4
leads to the formation of ventral mesoderm in the marginal
zone and epidermis in the ectoderm; inhibition of BMP-4
signaling promotes dorsal mesoderm and neural fate. These
studies indicate that a common set of activating and inhibi-
tory signaling molecules are involved in patterning the
animal hemisphere in both mesoderm and ectoderm. The
decision of animal hemisphere cells to form either meso-
derm or ectoderm however lies with the responding tissue
and the molecular basis of this competence remains un-
known.
We report the isolation and characterization in Xenopus
of a new member of the Smad family, the homologue of the
human Smad7, that reveals another inhibitory signaling
pathway involved in early patterning events. Smad7 inhib-
its signaling mediated by ALK-4, and blocks the transcrip-
tional activation of mesodermal genes in the marginal zone.
Smad7 is able to directly induce neural tissue in animal
pole explants in the absence of mesoderm and endoderm.
The neural-inducing activity of Smad7 may be due to
inhibition of BMP-4 signaling because Smad7 can block
BMP-4-mediated mesoderm induction. The ability of
Smad7 to block mesoderm induction while promoting
ectodermal fate suggests that Smad7 may play a role in the
decision of animal hemisphere cells to form either meso-
derm or ectoderm.
MATERIALS AND METHODS
Isolation of Xenopus Smad7
Degenerate primers directed at the highly conserved C-terminal
MH2 domain of human and rat Smad7 clones were used in the
amplification in the polymerase chain reaction (PCR) from stage 11
embryo cDNA. The 360-bp fragment we obtained was subse-
quently used to screen a stage 17 phage library (gift of C. Kintner).
The 14 positive clones analyzed revealed almost identical se-
quences. The complete nucleotide sequence of the longest clone
containing the full-length Xenopus Smad7 has been deposited in
GenBank under Accession No. AF045742.
Animals and Reagents
Embryos were obtained from Xenopus laevis adult frogs
(NASCO and Xenopus 1) by hormone-induced egg-laying and in
vitro fertilization using standard protocols and staged according to
Nieuwkoop and Faber. For phenotypic analysis, embryos were
injected in two blastomeres of four-cell embryos. The dorsal side of
the four-cell embryos was identified by pigment and cell size
difference between dorsal and ventral blastomeres. For in situ
hybridization analysis, albino embryos were injected in both blas-
tomeres at the two-cell stage without any dorsal/ventral bias.
Animal Pole Explant Assay
Two-cell-stage embryos were injected with RNAs spread in both
blastomeres and allowed to develop until animal pole explants
were cut at blastula stage (stage 9). Animal caps were dissected in
0.53 MMR containing penicillin and streptomycin. Animal caps
were harvested for RNA using acid guanidinium–phenol–chloro-
form method (TRI Reagent). Expression of specific RNA transcripts
was analyzed using an RT–PCR protocol as described (Wilson and
Melton, 1994). Smad7 primers: Forward, 59-cgatcggtgctcgtcc-39;
reverse, 59-actccaccgcctgca-39.
Plasmid Constructs and in Vitro Transcription
All constructs used for in vitro transcription and in-
jection were inserted into a CS21 vector (Turner and Weintraub,
1994). Most of the 59 and 39 untranslated sequences of all the
cDNAs used were removed before inserting into the vector. RNA
was synthesized in vitro using SP6 polymerase.
In Situ Hybridization and Probe Synthesis
The whole mount in situ hybridization protocol developed by
Harland (1991) was used with minor modifications. Digoxigenin-
labeled RNA probes were generated by in vitro transcription.
Hybridization was detected with an alkaline-phosphatase-coupled
anti-digoxigenin antibody and visualized using either NBT/BCIP or
BM purple as a substrate (Boehringer-Mannheim). Stained embryos
were fixed overnight in MEMFA, washed in ethanol, and photo-
graphed directly.
Histology
Embryos were washed in 70% ethanol before dehydrated
through an ethanol series and embedded in paraffin using standard
procedures. Tissues were sectioned at 10 mm on a rotary microtome
and mounted on gelatin-subbed slides. Sections were then stained
with eosin.
RESULTS
Xenopus Smad7 Is Enriched in the Ventral Side
of the Animal Hemisphere at Blastula Stages
The Xenopus Smad cDNA we isolated encodes a pre-
dicted 382-residue polypeptide with structural features of
the Smad family, such as the two conserved domains
known as MH1 and MH2 (for mad homology). Sequence
comparison with the known Smad family members re-
vealed that the clone we isolated is distantly related to the
pathway-restricted Smads (Smad1, Smad2, Smad3, Smad5,
Smad8) and closely related to the human inhibitory Smad,
Smad7 (Chen et al., 1997b; Graff et al., 1996; Hayashi et al.,
1997; Suzuki et al., 1997a). The Xenopus clone as well as
the human Smad7 cDNA lacks the carboxy-terminal SSXS
motif that serves as a receptor phosphorylation site in
receptor-regulated Smads (Kretzschmar et al., 1997; Macias
et al., 1996). The human Smad7 is predicted to be 426
amino acid long and contains a few stretches of amino acids
in the N-terminal MH1 domain not found in the Xenopus
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clone (Fig. 1) (Topper et al., 1997). Other than the absence of
these loops, the Xenopus clone is virtually identical to the
human Smad7 and thus we refer to it as Xenopus Smad7
(Fig. 1). We also found that the human Smad7 and Xenopus
Smad7 behaved in a similar fashion in functional assays
described later (data not shown). Smad7 is expressed mater-
nally and zygotically transcribed at fairly constant levels
during early development (Fig. 2, left). To further explore
the distribution of Smad7 transcripts, blastula-stage em-
bryos were dissected into animal and equatorial/vegetal
regions and cultured until the mid-gastrula stage (stage 11).
Smad7 was found to be localized predominantly in the
animal pole region (Fig. 2, right). To determine the dorsal/
ventral localization of Smad7, early-gastrula-stage embryos
were dissected into dorsal and ventral halves and analyzed
at mid-gastrula stage. Smad7 was found to be enriched in
the ventral half of the embryo, though low levels of Smad7
could be detected in the dorsal hemisphere (Fig. 2, right). In
situ hybridization techniques could not reliably detected
Smad7 expression in blastula-stage embryos.
Smad7 Blocks ALK-4 Signaling
Since specification of embryonic cell fate is known to
involve TGF-b family signaling, we assessed the biological
function of Smad7 during early development of Xenopus
embryos. TGF-b family members such as activin can mimic
the vegetal signals in the embryo and signal through ALK-4
and Smad2 to induce animal pole explants to form meso-
derm (Bhushan and Vale, manuscript submitted; Baker and
Harland, 1996; Chang et al., 1997) . Cell culture studies
suggest that the human Smad7 functions as an inhibitor of
TGF-b signaling. Smad7 has been shown to associate with
the type I TGF-b receptor, ALK-5 and to prevent signaling
by presumably blocking Smad2/3 activation (Hayashi et al.,
1997). We tested whether Smad7 would inhibit ALK-4
signaling by coinjecting Smad7 RNA with constitutively
active ALK-4 (CA-ALK-4) RNA into the animal pole of
two-cell stage embryos. Two batches of animal pole ex-
plants from these embryos were cultured and RNA was
extracted from the explants at the equivalent of mid-
FIG. 1. Structure of Xenopus Smad7. Alignment of the predicted amino acid sequences of human Smad7 and Xenopus Smad7. Identical
residues are shaded in dark. Mad homology domains, MH1 and MH2 are indicated by arrows.
FIG. 2. Localization of Smad7 during development. (Left) RNA
isolated from embryos at various stages as indicated in the figure
was analyzed by RT–PCR for the expression of Smad7 transcripts.
(Right) Blastula-stage embryos dissected into different regions and
cultured until equivalent of early gastrula stage. AP, animal pole;
M/V, marginal zone and vegetal region; D, dorsal half; V, ventral
half; E, whole embryo; 2RT, whole embryo extracted RNA in the
absence of reverse transcriptase in the RT–PCR reaction.
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gastrula-stage embryo (stage 11) and at late neurula stage
(stage 17). At gastrula stages the transcriptional activation
of a variety of mesoderm-specific genes can be analyzed in
the animal pole explants that reflect the induction and
pattern of mesoderm in the embryo. We have utilized four
such markers that broadly represent spatially distinct me-
soderm at gastrula stages: Cerberus (Cer), a secreted factor
expressed in the endomesodermal cells, goosecoid (gsc), a
homeobox gene expressed in the Spemann’s organizer,
Xenopus brachyury (Xbra), a gene present throughout the
marginal zone, and Wnt-8, a member of the Wnt family
expressed in the ventral mesoderm (Bouwmeester et al.,
1996; Cho et al., 1991; Christian et al., 1991; Smith et al.,
1991). Injection of 500 pg of CA-ALK-4 RNA alone acti-
vated of all four markers, while uninjected control explants
did not express any of the mesoderm markers (Fig. 3A).
Coinjection of 25 pg of Smad7 RNA along with 500 pg of
CA-ALK-4 RNA significantly inhibited transcriptional ac-
tivation of cer and gsc but did not affect induction of Xbra
or Wnt-8. A 10-fold increase in the injected amount of
Smad7 RNA (250 pg) however was sufficient to inhibit the
expression of Xbra and Wnt-8 in addition to cer and gsc.
RNA extracted from explants at the equivalent of neurula
stage embryos was analyzed for markers of differentiated
tissue that derived from both mesoderm and ectoderm (Fig.
3B). Explants injected with CA-ALK-4 RNA induced
muscle actin expression, a marker for somitic mesoderm.
Coinjection of Smad7 RNA at low levels did not inhibit the
expression of muscle actin, although higher levels of Smad7
blocked muscle actin expression completely. In this re-
spect, Smad7 inhibition of muscle actin expression follows
a similar profile as Xbra and Xwnt-8 analyzed at the gastrula
stages. Thus, the analysis of gastrula- and neurula-stage
mesoderm markers showed that Smad7 inhibited the for-
mation of a range of mesoderm cell types by blocking
signaling mediated by ALK-4. The analysis of the ectoder-
mal marker, NCAM, a general neural marker (Kintner and
Melton, 1987), however, yielded a surprising result. Ex-
plants coinjected with 250 pg of Smad7 and CA-ALK-4
RNA did not express muscle actin as just described but
expressed NCAM. This experiment pointed to an intriguing
result: inhibition of mesoderm markers by Smad7 coincided
with induction of neural fate.
Smad7 Promotes Neural Fate
To directly study the role of Smad7 in the induction of
ectodermal fates, we injected various levels of Smad7 RNA
in the animal pole of two-cell stage embryos. Explants were
dissected from blastula-stage embryos and RNA was ex-
tracted from the explants when sibling embryos reached the
equivalent of late neurula stage (stage 17). Explants from
embryos injected with Smad7 expressed high levels of the
neural-specific marker, NCAM (Fig. 4A). Injection of as
little as 25 pg of Smad7 RNA resulted in expression of
NCAM. We also analyzed these explants for the expression
of muscle actin and endodermin (edd), a panendodermal
marker (Sasai et al., 1996). No muscle actin or edd expres-
sion was detected in Smad7-injected embryos. To confirm
that no mesoderm was induced, explants injected with
various levels of Smad7 RNA were analyzed at mid-gastrula
stage for the expression of panmesoderm marker, Xbra. No
Xbra expression was detected in these explants (Fig. 4A).
The induction of neural fate by Smad7 thus appeared to be
direct, i.e., occurred in the absence of mesoderm or
endoderm induction. Analysis of markers for other ectoder-
mal fates such as the cement gland marker XAG (Sive and
Bradley, 1996) revealed that explants from Smad7 embryos
also expressed high levels of XAG. The epidermal fate
marker, epidermal keratin, is normally expressed in unin-
jected caps and usually inhibited upon neural induction
(Wilson et al., 1997). In Smad7-injected explants, epidermal
keratin expression was significantly reduced.
Several lines of evidence suggest that neural specifica-
tion is under inhibitory control and that neural-inducing
signals function by antagonizing BMP-4 in the ectoderm
allowing neural tissue to form as a default state (reviewed
in (Wilson and Hemmati-Brivanlou, 1997). We tested
whether Smad7 could block BMP-4 signaling. BMP-4 has
been shown to induce a variety of early response genes in
ectodermal explants including Xwnt-8, Xbra, Vox (Xvent-
FIG. 3. Smad7 blocks ALK-4-mediated mesoderm induction in
explant assays. (A) Animal pole explants from embryos injected
with 500 pg of CA-ALK-4 alone and coinjected with Smad7
(amounts as indicated) were analyzed by RT–PCR at stage 11 for
the expression of mesoderm-specific markers expressed at gastrula
stages. EF1-a transcripts used as an internal standard. Cer, cerbe-
rus; Gsc, goosecoid; Xbra, brachyury. 2RT lane not shown for this
experiment. (B) Animal pole explants from embryos injected with
500 pg of ALK-4 alone and coinjected with Smad7 (amounts as
indicated) were analyzed by RT–PCR at stage 17 for the expression
of mesoderm and ectoderm differentiated markers. NCAM, neural-
specific marker; muscle actin, somitic mesoderm marker; 2RT,
whole embryo extracted RNA in the absence of reverse transcrip-
tase in the RT–PCR reaction.
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2), and Msx1 (Onichtchouk et al., 1996; Schmidt et al.,
1996; Suzuki et al., 1997b). Embryos at the two-cell stage
were injected with 500 pg of BMP-4 RNA alone or
coinjected along with different amounts of Smad7 RNA.
Explants were dissected at late-blastula stage and ana-
lyzed at mid-gastrula equivalent stage for the induction
of these early response markers to BMP-4. Analysis of
RNA extracted from mid-gastrula-stage explants (Fig. 4B)
showed that BMP-4 can mediate induction of the ventral
mesoderm marker, Xwnt-8, and the panmesodermal
marker, Xbra. Vox and Msx1 are normally expressed in
the nonneural ectoderm in addition to ventral mesoderm
and uninjected explants express both these markers,
though BMP-4 is capable of significantly increasing their
levels of expression (Fig. 4B). Coinjection of low doses of
Smad7 with BMP-4 completely blocks the induction of
both Xbra and Xwnt8, although Vox and Msx1 are unaf-
fected. At higher doses of injected Smad7, however, Vox
and Msx1 expression in explants is also inhibited to
levels lower than uninduced explants. These experiments
show that Smad7 could promote neural fate in ectoder-
mal explants by blocking BMP-4 signaling.
Smad7 Acts Downstream of the Receptor
Activation
To ascertain where Smad7 acted in the signaling cascade,
we also determined whether Smad7 was capable of inhibit-
ing pathway-specific Smad involved in ALK-4- and BMP-4-
mediated signaling. Explants injected with Smad2 and
Smad1, in a ligand-independent fashion, activate dorsal and
ventral markers, respectively (Graff et al., 1996). Explants
injected with 1 ng of Smad2 RNA expressed dorsal meso-
derm marker, muscle actin, while explants injected with 1
ng Smad1 RNA expressed ventral mesoderm marker, globin
(Fig. 5). Coexpression of 250 pg of Smad7 RNA had no effect
on either Smad activity because muscle actin and globin
induction was unaffected. It is important to note that this
level of Smad7 was sufficient to inhibit all target genes
activated by CA-ALK-4 and BMP-4. However, in explants
coinjected with higher levels of Smad7 (1 ng), muscle actin
and globin were not detected, suggesting that relatively
high levels of Smad7 are required to block Smad2 and
Smad1 activities.
Smad7 Blocks Mesoderm Formation in the Embryo
We tested whether Smad7 also blocked mesoderm signals
in the marginal zone in the embryo. Albino embryos were
injected with Smad7 RNA in the marginal zone of both
blastomeres of two-cell-stage embryos. At early gastrula
stage, embryos were analyzed by in situ hybridization for
the induction of a range of mesoderm-specific genes. Two
representative markers are shown here: goosecoid, which is
expressed in the dorsal lip, and Vox (Xvent-2), a gene
expressed in ventral mesoderm outside the dorsal lip region
FIG. 4. Smad7 activates the default neural pathway. (A) Explants
from embryos injected with Smad7 (amounts indicated) alone and
analyzed for the expression of differentiated markers for all germ
layers. EF1-a transcripts used as an internal standard. NCAM, neural-
specific marker; edd, endodermin—panendoderm marker; XAG,
cement gland marker; muscle actin, somitic mesoderm marker;
epidermal keratin, epidermis marker; Xbra, Xenopus brachyury, pan-
mesoderm marker. (B) Smad7 blocks BMP-4-mediated induction of
mesoderm. Embryos were injected with 500 pg of BMP-4 RNA alone
or coinjected with 500 pg of BMP-4 RNA and Smad7 RNA (amounts
indicated). Explants at blastula stage were cultured until gastrula stage
and analyzed for the expression of mesoderm markers by RT–PCR.
2RT, whole embryo-extracted RNA in the absence of reverse tran-
scriptase in the RT–PCR reaction.
FIG. 5. Smad7 has similar effects on Smad1 and Smad2 activities.
(Left) Animal pole explants from embryos injected with 1 ng of
Smad1 alone and coinjected with Smad7 (amounts as indicated in
ng) were analyzed by RT–PCR at stage 17 for the expression of
globin, a ventral mesoderm marker. (Right) Animal pole explants
from embryos injected with 1 ng of Smad1 alone and coinjected
with Smad7 (amounts as indicated in ng) were analyzed by RT–
PCR at stage 17 for the expression of muscle actin, somitic
mesoderm marker. NCAM, neural-specific marker used as a posi-
tive control for Smad7; 2RT, whole embryo-extracted RNA in the
absence of reverse transcriptase in the RT–PCR reaction.
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(Figs. 6A and 6C). In Smad7-injected embryos, expression of
either goosecoid and Vox was not detected (Figs. 6B and 6D).
Other markers such as Xbra and Xwnt-8 were also blocked
by Smad7 (data not shown). The injection of human Smad7
in Xenopus embryos was also reported to block Xbra ex-
pression, suggesting that Xenopus and human Smad7 be-
have in a similar fashion (Nakao et al., 1997).
Since Smad7 blocked gene expression in the mesoderm
and the formation of mesoderm is crucial for the establish-
ment of the body plan, we analyzed the phenotype of
embryos that were injected with Smad7. Embryos injected
with Smad7 RNA in the marginal zone of both blastomeres
of two-cell-stage embryos did not initiate gastrulation,
consistent with the inability of these embryos to form any
mesoderm (data not shown). We targeted the expression of
Smad7 by injecting either dorsal or ventral blastomeres of
four-cell-stage embryos. Embryos injected in the dorsal
blastomeres showed severely truncated anterior axes and
FIG. 6. (Top) Smad7 blocks activation of mesoderm markers in the embryo. Albino embryos were injected with 25 pg of Smad7 RNA in
the marginal zone of both blastomeres at the two-cell stage. The embryos were fixed at gastrula stage 10. One-half and whole mount in situ
hybridization was performed using Gsc or Vox antisense probes. (A) Uninjected embryo—Gsc is expressed in the dorsal lip. (B) Embryo
injected with Smad7—Gsc is no longer detected (n 5 22). (C) Uninjected embryo—Vox is expressed in the ventral mesoderm and excluded
from the dorsal lip. (D) Embryo injected with Smad7—Vox is no longer detected (n 5 16).
FIG. 7. (Bottom) Smad7 blocks mesoderm formation and affects body axis in the embryo. Embryos injected with 25 pg of Smad7 RNA. (A)
Uninjected embryos. (B) Histological section of uninjected embryos. (C) Embryos injected in a dorsal blastomeres at four-cell stage (n 5 37,
21). (D) Histological section of dorsally injected Smad7 embryos—note the lack of dorsal mesodermal tissue, an enlarged cement gland, and
the presence of a neural tube. (E) Embryos injected with Smad7 RNA in ventral blastomeres at four-cell stage (n 5 28)—note incomplete
secondary axes. (F) Histological section of embryos injected with Smad7 ventrally—note that the secondary axis does not contain any
notochord or somitic mesoderm. cg, cement gland; nt, neural tube; s, somites; ov, otic vessicle; nt, notochord.
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most lacked head structures, although these embryos had
prominent cement glands (Fig. 7C). The b-gal lineage tracer
patterns in the dorsal axes suggested that somites either
were not formed at all or were disordered. Histological
sections confirmed that these embryos lacked dorsal meso-
derm structures such as notochord and somites (Fig. 7D).
Interestingly, these embryos did appear to have, at least by
histological criteria, a well-formed neural tube. Embryos
injected in ventral blastomeres displayed incomplete sec-
ondary axes, consistent with the ability of Smad7 to block
ventral mesoderm formation by BMP-4 (Fig. 7E). Histolog-
ical sections showed that the secondary axes were devoid of
any histologically defined mesodermal tissue and appeared
disorganized (Fig. 7F).
DISCUSSION
Signals from the vegetal region of the Xenopus embryo
induce overlying marginal zone cells to form mesoderm.
The mesoderm-inducing signals are mimicked by TGF-b
members, activin, Vg1 and nodal-related molecules and are
likely to be mediated by the serine kinase receptor, ALK-4,
and its downstream mediator, Smad2. In this study, we
have investigated the role of a new member of the Smad
family, Xenopus Smad7, in the induction of mesoderm.
Smad7 is expressed at fairly constant levels throughout
early development. At blastula and gastrula stages Smad7
transcripts are enriched in the ventral part of the animal
hemisphere, although low levels of Smad7 transcript are
detected in the dorsal side of the animal hemisphere. We
demonstrate that Smad7 blocks the induction of mesoderm
mediated by ALK-4. We also found the inhibitory activity of
Smad7 in blocking transcriptional activation of mesoderm
markers to be graded: lower levels of Smad7 blocked expres-
sion of dorsal mesoderm markers, while higher levels
blocked all mesoderm. Since activation of dorsal mesoderm
genes requires the highest concentration of inducer (Green
and Smith, 1990), lower levels of Smad7 would presumably
lead to partial inhibition of ALK-4 activity and that would
be sufficient to block activation of the genes that require
the highest activity. This suggests that Smad7 may play a
negative regulatory role in the establishment of the pattern
of mesodermal gene expression. The pattern of Smad7 RNA
expression, i.e., higher in the ventral hemisphere and lower
dorsally, is consistent with this proposed role. There is
growing evidence of regulatory processes that underlie
spatial organization of gene transcription in the embryo
that utilizes negative control. The syncytial early Drosoph-
ila embryo sets up spatial transcription patterns that de-
pend on both positive and negative transcription control
(reviewed in Davidson, 1993). In Xenopus, activin has been
shown to activate as well as inhibit gene transcription in
animal explants and dissociated cells in a concentration-
dependent manner (Green and Smith, 1990; Gurdon et al.,
1994), suggesting that the signal transduction mechanism
involves some sort of negative regulatory control. Observa-
tions in the whole embryo suggest that a more cascade-like
series of patterning involving negative feedback signaling
may operate in the embryo, since even under experimental
conditions, various induced tissue such as notochord,
somites, lateral mesoderm, and ectoderm remain in propor-
tion (Cooke, 1989). In addition, theoretical modeling that
includes an inhibitory component is better at simulating
the regulatory behavior of pattern formation in the em-
bryo (Meinhardt, 1977). Whether Smad7 may play a role in
a negative regulatory signaling cascade to control gene
expression patterns in the embryo remains to be fully
explored.
The human Smad7 was shown to function in cell culture
studies as an intracellular antagonist of TGF-b signaling
(Hayashi et al., 1997; Nakao et al., 1997). We have shown
here that Smad7 blocks signaling mediated by the activin
receptor ALK-4 as well as inhibit BMP-4 signaling. These
results reveal that Smad7 could act as a general inhibitor of
the TGF-b superfamily. Smad7 can efficiently block signal-
ing from activated type I receptors, ALK-4 and ALK-5, and
associates stably with these activated type I receptors
(Hayashi et al., 1997; Nakao et al., 1997). This suggests that
the Smad7 may interfere with the activation of the
pathway-specific Smads. Our results show that Smad7, at
levels more than sufficient to block the activity of activated
receptors, does not block pathway-specific Smads, Smad1
and Smad2, activities. Unlike the related inhibitory Smad6
(Hata et al., 1998), no direct physical interactions between
Smad7 and pathway-specific Smads have been observed
(unpublished data). Smad7 and Smad6 were however re-
ported to form heterodimers (Topper et al., 1997). It is
possible that the block of pathway-specific Smads at high
levels of Smad7 expression may be mediated through
Smad6. Further biochemical analysis could help in the
clarification of the specificity and the site of action of the
inhibitory Smads.
The direct neural-inducing activity of Smad7 in ectoder-
mal explants most likely originates in its ability to block
BMP-4 signaling. The Spemann’s organizer produces a host
of secreted factors that have direct neural-inducing activity
in animal pole explants. Two such secreted factors from the
dorsal mesoderm, follistatin and cerberus, have activity
similar to Smad7 (Bouwmeester et al., 1996; Hemmati-
Brivanlou et al., 1994). Both follistatin and cerberus inhibit
mesoderm induction and induce neural tissue in explants.
Follistatin-blocking mesoderm induction in explants is
consistent with its ability to inhibit activin; however, its
neural-inducing activity may arise from follistatin inhibit-
ing other members of the TGF-b family such as BMP-4.
Unlike Smad7, however, follistatin does not prevent meso-
derm formation in embryos (Schulte et al., 1994). Cerberus
suppresses dorsal and ventral mesoderm gene expression
and promotes the formation of cement gland and neural
structures. However, unlike Smad7, cerberus does activate
the panendodermal marker, edd, in animal pole explants. It
may, however, be worth pursuing the relationship of cerbe-
rus with Smad7, since it is possible that Smad7 could
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function downstream of cerberus and mediate some of its
activities.
Noggin and chordin are two other factors expressed in the
Spemann’s organizer that have been shown to directly bind
BMP-4 and this activity is sufficient to initiate the pathway
for neural development (Piccolo et al., 1996; Zimmerman et
al., 1996). Smad7, like noggin and chordin, blocks BMP-4-
mediated activation of ventral mesoderm and thus initiates
neural development in animal pole explants. However,
three activities of Smad7 distinguish it from noggin and
chordin. First, Smad7 is a potent inhibitor of all mesoderm,
while noggin and chordin dorsalize ventral mesoderm.
Second, noggin and chordin induce explants to activate edd
expression and form endoderm in addition to neural tissue
(Sasai et al., 1996) while Smad7-expressing explants do not
activate edd. Finally, blocking BMP-4 signaling in explants
by injecting dominant negative BMP-4 receptor or noggin
induces neural fate at the expense of other ectodermal cell
types such as for cement gland and epidermis (Wilson et al.,
1997). Smad7, by contrast, induces high levels of cement
gland marker and does not completely suppress the epider-
mal marker. The expression of epidermal keratin we ob-
serve, however, could be simply due to Smad7 RNA not
distributed throughout the animal pole, thus allowing ex-
pression of this very abundant marker. These differences
nevertheless indicate that despite the ability of Smad7 to
directly induce neural tissue in explants, its role in the
embryo may be quite different from the secreted BMP-4
antagonists such as noggin and chordin.
Our results lead us to speculate that the role of Smad7 in
the embryo may more likely lie in the establishment of
spatial limits for the expression of mesodermal genes. Since
in vitro assays for mesoderm induction are based on the
ability of animal pole explants to form mesoderm, animal
pole cells are clearly capable of forming mesoderm; yet in
the embryos, only cells in the marginal zone of the animal
pole form mesoderm. Several mechanisms have been pro-
posed that would limit the extent of induction such as the
rate of diffusion, concentration, or the stability of the
ligands (Gurdon, 1987; Weeks and Melton, 1987). On the
other hand, ectodermal explants lose the ability to respond
to mesoderm inducers at gastrula stages and thus temporal
competence could also limit the extent of mesoderm for-
mation (Slack, 1993). Whether Smad7 plays a role in estab-
lishing the germ layer domains in the early vertebrate
embryo by limiting the spatial extent of induction remains
to be determined. Nevertheless, the isolation and charac-
terization of Smad7 as a potent inhibitor of mesoderm
induction in vitro and in vivo suggests that Smad7 may
negatively regulate embryonic induction in the embryo.
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